Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Swiss Entertainment Update.
Press releases published on July 1, 2025
Daughter of detained Syrian man appeals to UN Special Envoy for help
EIN Presswire
·
July 1, 2025
Suleiman Khalil, former mayor of Sadad, has been held incommunicado since February 8. GENEVA, SWITZERLAND, July 1, 2025 /EINPresswire.com/ -- The daughter of Suleiman Khalil, the former mayor of Sadad in Syria, has written to the UN Special Envoy for …
Lutroo Imaging Begins Phase 1 Clinical Trial of Radiocaine™, a First-in-Class PET Radiotracer for Pain Imaging
EIN Presswire
·
July 1, 2025
Study marks first-in-human use of Radiocaine™ to image pain-related sodium channels with positron emission tomography (PET) PALO ALTO, CA, UNITED STATES, July 1, 2025 /EINPresswire.com/ -- Lutroo Imaging, a clinical-stage molecular imaging company, …
Balfour Capital Group Welcomes Gerald Kotollaku as Investment Advisor
EIN Presswire
·
July 1, 2025
Hedge Funds, Investments, Trading YVERDON-LES-BAINS, SWITZERLAND, July 1, 2025 /EINPresswire.com/ -- Balfour Capital Group is proud to welcome Gerald Kotollaku to its global advisory platform. With a strong record in financial analysis, risk management, …
XS.com nomme Marcus Ng directeur régional pour la région Asie-Pacifique (APAC)
EIN Presswire
·
July 1, 2025
SWITZERLAND, July 1, 2025 /Business News/ -- XS.com, le courtier mondial multi-actifs, est heureux d’annoncer la nomination de Marcus Ng au poste de nouveau directeur régional pour la région Asie-Pacifique (APAC), dans le cadre de l’expansion continue du …
SC Capital Holding in Advanced Talks for Strategic Hospitality Acquisition in Cyprus
GlobeNewswire
·
July 1, 2025
ZUG, Switzerland, July 01, 2025 (GLOBE NEWSWIRE) -- Switzerland-based SC Capital Holding AG confirmed today that it is in late-stage discussions to acquire a landmark luxury hotel on the southern coast of Cyprus, marking the firm’s entry into the island …
ReproNovo Announces First Participant Included in U.S. Phase 2 Trial of RPN-001 for Male Infertility
GlobeNewswire
·
July 1, 2025
RPN-001 is a novel orally administered aromatase inhibitor being developed for the treatment of infertility in men with low serum testosterone No FDA-approved oral therapies currently exist for this underserved population LAUSANNE, Switzerland and …